Streetbeat News

Products Services

ACHV

Achieve Life Sciences has initiated the ORCA-OL clinical trial to evaluate the long-term exposure of Cytisinicline for users of nicotine e-cigarettes and smokers.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:04 pm

TNXP

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) will present a study involving TNX-1500 at the American Transplant Congress 2024. The company will have two oral presentations and a poster presentation at the event, which will be held from June 1-5, 2024, in Philadelphia.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:04 pm

AAPL

GOOG

GOOGL

INTC

MSFT

Apple's upcoming iPhone 16 with AI integration is set to launch soon, with a report predicting that over half of the world's smartphones will be AI-capable by 2028. Major players like Apple, Google, and Samsung are leading this trend. The AI smartphone market is gaining momentum, with significant advancements expected in the coming years.

Portfolio Pulse from Rounak Jain

May 29, 2024 | 12:04 pm

GENE

Genetic Technologies Limited (NASDAQ: GENE) has launched geneType, a new comprehensive risk assessment test for breast and ovarian cancer, covering 100% of women at risk. The test is available to women above 30 and assesses both hereditary and sporadic cancer risks.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:03 pm

VBIV

VBI Vaccines has reported new tumor response data from its ongoing Phase 2b study of VBI-1901 for recurrent glioblastoma. Among 7 patients, one showed a partial tumor response and two had stable disease. The disease control rate in the VBI-1901 arm was 43%, compared to 0% in the control arm. The FDA has granted Fast Track and Orphan Drug Designations to VBI-1901. Additional interim data is expected in Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:02 pm

DARP

NVDA

SMH

TSM

Nvidia Corp (NVDA) is accelerating the use of Fan-Out Panel Level Packaging (FOPLP) for its GB200 AI server chips to address production constraints at Taiwan Semiconductor Manufacturing Co (TSM). This move is expected to reduce costs and enhance capacity. Nvidia's stock has gained over 184% in the last 12 months, and investors can gain exposure through ETFs like VanEck Semiconductor ETF (SMH) and Grizzle Growth ETF (DARP).

Portfolio Pulse from Anusuya Lahiri

May 29, 2024 | 11:54 am

RSLS

ReShape Lifesciences Inc. (NASDAQ:RSLS) saw its stock surge over 100% in pre-market trading after receiving approval from the U.S. Patent And Trademark Office for its obesity treatment devices. The approval is subject to a fee due on Aug. 26, 2024. This comes amid increasing demand for weight-loss drugs like Ozempic and WeGovy. At the time of writing, RSLS was trading 82.87% higher at $0.380.

Portfolio Pulse from Pooja Rajkumari

May 29, 2024 | 11:49 am

IKNA

Ikena Oncology shares are trading higher after the company announced it will discontinue development of IK-930 and evaluate strategic options for both the Company and its development pipeline.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:48 am

JAZZ

Jazz Pharmaceuticals' zanidatamab has been granted FDA Priority Review for the treatment of advanced HER2-positive biliary tract cancer. The FDA has set a target action date of November 29, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:47 am

ARKF

ARKK

HOOD

Robinhood Markets, Inc (NASDAQ:HOOD) stock is trading higher after announcing a $1 billion share buyback program. The company also introduced tiered margin rates and expanded its retirement offerings. Analysts are bullish due to better economic conditions and new product launches. HOOD stock has gained over 129% in the last 12 months. Investors can also gain exposure through ARK Fintech Innovation ETF (NYSE:ARKF) and ARK Innovation ETF (NYSE:ARKK).

Portfolio Pulse from Anusuya Lahiri

May 29, 2024 | 11:46 am